We all hope to make a fortune over time thanks to our investments. It's impossible to guarantee one particular stock will do the trick. But by carefully choosing companies that offer earnings growth -- or potential for earnings growth -- we improve our chances of building wealth.

Healthcare is a great place to look for these sorts of players. That's because the industry is filled with innovators and market leaders. Right here, I'll talk about a dynamic biotech company that may be months away from commercializing its first product -- based on game-changing technology. And I'll talk about the leader in a high-growth surgical market. These stocks both have declined in recent times, leaving them at bargain prices. And that's another incentive to pick them up now.

CRISPR Therapeutics (NASDAQ: CRSP) works in the cutting-edge area of gene editing. This involves fixing faulty DNA responsible for disease. The company uses the CRISPR/Cas9 technique -- the cutting of DNA so that a natural repair process can happen. The idea is to tackle genetic diseases right at the source of the problem.

Continue reading

Source Fool.com